Starpharma to Speak at ACCESS ASIA Partnering Forum | Online Showcase

September 25, 2025 (9:30 AM CST) — We’re pleased to announce that Tony Eglezos, Commercialisation and Licensing Executive of Starpharma, will present at the ACCESS Asia Partnering Forum Online Showcase. ACCESS Asia builds on the success of ACCESS China, expanding Asia’s leading cross-border biotech platform to connect innovators with global pharma, investors, and partners

About Starpharma

Starpharma (ASX: SPL) is an ASX-listed biopharmaceutical company with over 20 years of dendrimer science expertise and a strong IP portfolio spanning 19 patent families and 150+ granted or pending patents. Its lead technology, the DEP® ADC Platform, is an advanced dendrimer-based approach that enhances antibody-drug conjugates by improving homogeneity, enabling higher and more controlled payload delivery, and expanding the therapeutic window for safer, more effective cancer treatments.

About the speaker

Tony Eglezos is an experienced Commercialisation and Licensing Executive with a proven record of Leadership and global experience across Australia, the United States, and Europe. Tony has held senior leadership roles at leading companies including CSL, Amgen, Abbott Laboratories, and Abbott Australasia.Tony has extensive experience in acquisitions, due diligence, product commercialisation, global R&D partnerships and management of commercial teams.Tony holds a PhD in Immunology from the University of Melbourne and an MBA from the University of Technology Sydney.

About ACCESS ASIA Partnering Forum

ACCESS Asia Partnering Forum Online Showcase is scheduled to be held on September 25, 2025, 9:30 AM (China Standard Time) via Zoom.
This event will spotlight the 1st wave of 100 innovators, providing them with a global stage to showcase pipelines and connect with pharma, investors, and strategic partners worldwide.

Conference Name: ACCESS Asia Partnering Forum Online Showcase
Date & Time: September 25, 2025, 9:30 AM (China Standard Time)
View more information at: https://biotochina.org/